日本柳杉花粉症患者舌下免疫治疗依从性与脱落相关因素分析
该研究基于日本行政索赔数据,回顾了2014年10月至2016年6月期间接受日本柳杉花粉提取物舌下免疫治疗的1236例患者(846例成人,249例青少年)。成人1年和2年队列脱落率分别为13.5%和22.1%,依从率分别为92.8%和88.8%;青少年脱落率更高、依从性更低。40-59岁成人脱落风险低于20-29岁成人。
要点
- 成人1年队列脱落率13.5%、依从率92.8%,2年队列分别为22.1%和88.8%。
- 青少年较成人脱落率更高、依从性更低。
- 40-59岁成人脱落风险低于20-29岁成人。
核心结论
- 高脱落率与较年轻年龄组相关。
- 成人依从性与年龄、全身性类固醇用药史和性别相关,青少年中未观察到这些关联。
研究设计与样本
- 回顾性行政索赔数据分析,纳入2014年10月至2016年6月期间有日本柳杉花粉提取物处方的1236例日本患者,包括846例成人(平均年龄43.0岁,女性41.8%)和249例青少年(平均年龄14.1岁,女性36.6%)。
- 按开始舌下免疫治疗的年份分为1年队列和2年队列,使用多因素Cox回归和线性回归模型计算脱落率和依从性并识别相关因素。
主要发现
- 成人1年队列脱落率为13.5%、依从率为92.8%;2年队列脱落率为22.1%、依从率为88.8%。
- 40-49岁成人1年队列和2年队列的脱落风险比(95%CI)分别为0.26(0.12-0.58)和0.40(0.17-0.93)。
- 50-59岁成人1年队列和2年队列的脱落风险比(95%CI)分别为0.32(0.14-0.75)和0.35(0.13-0.92)。
- 较年轻年龄与成人1年队列和2年队列较低依从性相关(p=0.001和p=0.02)。
- 全身性类固醇用药史和男性与成人依从性正相关,但在青少年中无此关联。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Sublingual immunotherapy (SLIT) is safe and effective but compliance is problematic. In this study we evaluated dropout and compliance among adults (≥20 years of age) and adolescents (<20 years of age) for Japanese cedar pollen extract (JCPE), an aqueous SLIT approved in 2014 in Japan. METHODS: Administrative claims data on 1236 Japanese patients, 846 adults (mean age, 43.0 years; 41.8% female) and 249 adolescents (mean age, 14.1 years; 36.6% female), with a JCPE prescription between October 2014 and June 2016 were reviewed. Adults and adolescents were divided according to the year they started SLIT (1- and 2-year cohorts) to calculate dropout and compliance and identify associated factors using multivariate Cox and linear regression models. RESULTS: In 1- and 2-year adult cohorts, dropout rates were 13.5% and 22.1% and compliance rates were 92.8% and 88.8%, respectively. Adolescents had higher dropout and lower compliance. Patients 40-59 years of age had a lower dropout risk than patients 20-29 years of age. Dropout hazard ratios (95% confidence interval) in 1- and 2-year cohorts were 0.26 (0.12-0.58) and 0.40 (0.17-0.93) in patients 40-49 years of age and 0.32 (0.14-0.75) and 0.35 (0.13-0.92) in patients 50-59 years of age, respectively. Younger age contributed to lower compliance in 1- and 2-year adult cohorts (p = 0.001 and p = 0.02, respectively). Systemic steroidal medication history and male gender were positively associated with compliance in adults but not in adolescents. CONCLUSION: High dropout rate was associated with younger generations. Compliance in adults, but not in adolescents, was associated with age, systemic steroidal medication history, and gender.
引用
- Imanaka T, Sato I, Kawasaki Y, et al. An analysis of factors associated with compliance and dropout of sublingual immunotherapy on Japanese cedar pollinosis patients. Int Forum Allergy Rhinol. 2019. PMID: 31173675. doi:10.1002/alr.22308
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。